Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease

Nature Medicine

Volumn 17, Issue 12, 2011, Pages 1668-1673

  Ebrahimkhani, Mohammad R ^a,b   Oakley, Fiona ^a   Murphy, Lindsay B ^a   Mann, Jelena ^a   Moles, Anna ^a   Perugorria, Maria J ^a   Ellis, Elizabeth ^a   Lakey, Anne F ^a   Burt, Alastair D ^a   Douglass, Angela ^a   Wright, Matthew C ^a   White, Steven A ^a   Jaffré, Fabrice ^c,d,e   Maroteaux, Luc ^c,d,e   Mann, Derek A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Center for Environmental Health Sciences   (United States)

^c Institut National de la Sante   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSTITUT DU FER À MOULIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; SEROTONIN 2B RECEPTOR; TRANSCRIPTION FACTOR JUND; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; DRUG SAFETY; DRUG TARGETING; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LIVER REGENERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STELLATE CELL; WILD TYPE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPATIC STELLATE CELLS; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; INDOLES; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2B; SEROTONIN; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; UREA; WOUND HEALING;

MUS;

EID: 84856094934     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2490     Document Type: Article

References (27)

1. Gurtner G.C., Werner S., Barrandon Y. & Longaker M.T. Wound repair and regeneration. Nature 453, 314-321 (2008). (Pubitemid 351693137)
2. Wallace K., Burt A.D. & Wright M.C. Liver fibrosis. Biochem. J. 411, 1-18 (2008). (Pubitemid 351482341)
3. Marshall A. et al. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 128, 33-42 (2005). (Pubitemid 40039956)
4. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25, 3818-3822 (2006). (Pubitemid 43980477)
5. Malik R., Selden C. & Hodgson H. The role of non-parenchymal cells in liver growth. Semin. Cell Dev. Biol. 13, 425-431 (2002). (Pubitemid 36027147)
6. Friedman S.L. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172 (2008).
7. Passino M.A., Adams R.A., Sikorski S.L. & Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 315, 1853-1856 (2007). (Pubitemid 46580146)
8. +/-mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology 37, 107-117 (2003). (Pubitemid 36042151)
9. Scobie B.A. & Summerskill W.H. Hepatic cirrhosis secondary to obstruction of the biliary system. Am. J. Dig. Dis. 10, 135-146 (1965).
10. Polimeno L. et al. Cell proliferation and oncogene expression after bile duct ligation in the rat: Evidence of a specific growth effect on bile duct cells. Hepatology 21, 1070-1078 (1995).
11. Wright M.C. et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121, 685-698 (2001). (Pubitemid 32822584)
12. Elrick L.J. et al. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells-a potential mechanism for targeting liver anti-fibrotic therapeutics. J. Hepatol. 42, 888-896 (2005). (Pubitemid 40693206)
13. Douglass A. et al. Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. J. Hepatol. 49, 88-98 (2008).
14. Cassiman D., Libbrecht L., Desmet V., Denef C. & Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol. 36, 200-209 (2002). (Pubitemid 34146426)
15. Omenetti A. et al. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab. Invest. 87, 499-514 (2007). (Pubitemid 46633127)
16. Lesurtel M. et al. Platelet-derived serotonin mediates liver regeneration. Science 312, 104-107 (2006).
17. Omenetti A. et al. Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. Am. J. Gastrointest. Liver Physiol. 300, G303-G315 (2011).
18. Ruddell R.G. et al. A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am. J. Pathol. 169, 861-876 (2006). (Pubitemid 44411953)
19. Forbes I.T., Jones G.E., Murphy O.E., Holland V. & Baxter G.S. N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: A novel, high-affinity 5-HT2B receptor antagonist. J. Med. Chem. 38, 855-857 (1995).
20. Varty G.B. & Higgins G.A. Reversal of dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT2 receptor antagonist ketanserin. Eur. J. Pharmacol. 287, 201-205 (1995).
21. Fausto N. Protooncogenes and growth factors associated with normal and abnormal liver growth. Dig. Dis. Sci. 36, 653-658 (1991).
22. Kim S.J. et al. Autoinduction of transforming growth factor β 1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10, 1492-1497 (1990). (Pubitemid 20105020)
23. Smart D.E. et al. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J. Biol. Chem. 276, 24414-24421 (2001).
24. Smart D.E. et al. JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation. Hepatology 44, 1432-1440 (2006). (Pubitemid 44953649)
25. Pillebout E. et al. JunD protects against chronic kidney disease by regulating paracrine mitogens. J. Clin. Invest. 112, 843-852 (2003). (Pubitemid 38063742)
26. Yang L., Besschetnova T.Y., Brooks C.R., Shah J.V. & Bonventre J.V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 16, 535-543 (2010).
27. Palmer M.J. Leads for the treatment of pulmonary hypertension. Expert Opin. Ther. Pat. 19, 575-592 (2009).